
    
      Study Objectives: Evaluate the safety and effectiveness of the UroLiftÂ® System when used in
      symptomatic benign prostatic hyperplasia (BPH) subjects with an enlarged median lobe.

      Study Design: Prospective, multicenter, non-blinded, single arm (non-randomized) study.

      Sample Size: A total of no more than 48 subjects will be enrolled. Subject Population: Males
      age of 50 years or older diagnosed with lower urinary tract symptoms (LUTS) with enlarged
      median lobe.
    
  